Action mechanism of antileukemic agents with special reference to nucleic acid metabolism of leukemic cells.
D015250:Aclarubicin; D000208:Acute Disease; D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D004247:DNA / Q000378:metabolism*; D007938:Leukemia / Q000097:blood / Q000188:drug therapy*; D009279:Naphthacenes / Q000627:therapeutic use; D011685:Purine Nucleotides / Q000096:biosynthesis; D011742:Pyrimidine Nucleotides / Q000096:biosynthesis
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D009279:Naphthacenes; D011685:Purine Nucleotides; D011742:Pyrimidine Nucleotides; D015250:Aclarubicin; D004247:DNA